Reportstack

Global PCOS Drugs Market 2014-2018

 

Naperville, IL -- (ReleaseWire) -- 05/05/2014 -- Reportstack, provider of premium market research reports announces the addition of Global PCOS Drugs Market 2014-2018 market report to its offering
About PCOS Drugs
PCOS, also known as Stein-Leventhal Syndrome, is one of the most common hormonal endocrine disorders in women. It is characterized by polycystic ovaries, irregular or no menstrual periods, irregular ovulation, and high levels of androgens (male hormones) in the body. The exact cause of PCOS is unknown. In PCOS, small cysts form on the ovaries, which do not produce a sufficient amount of hormone to initiate ovulation. The ovarian follicles, which are filled with fluid in preparation for ovulation, remain as cysts when ovulation does not occur. Lifestyle modifications, medication, and surgery are some of the currently available treatments for PCOS.
Analysts forecast the Global PCOS Drugs market will grow at a CAGR of 2.65 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global PCOS Drugs market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the sales of marketed, off-label, and generic drugs used in the treatment of PCOS.
Global PCOS Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global PCOS Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
Americas
EMEA
APAC
Key Vendors
Bristol Myers Squibb Co.
Merck & Co. Inc.
Novartis AG
Sanofi SA
Teva Pharmaceutical Inc.
Other Prominent Vendors

AstraZeneca plc
Catalysis SL
Crinetics Pharmaceuticals Inc.
Dexa Medica Group
EffRx Inc.
Neurocrine Biosciences Inc.
Market Driver
Increase in Patient Population.
For a full, detailed list, view our report.
Market Challenge
Lack of Approved Drugs.
For a full, detailed list, view our report.
Market Trend
Increase in Awareness of PCOS Drugs.
For a full, detailed list, view our report.
Key Questions Answered in this Report
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

Companies Mentioned

NeoStrata Co., NuSKin Enterprises, Orlane SA, Revlon Inc., Robanda International Inc., Shiseido Co., SkinMedica Inc. , Skinvisible Inc., Woodridge Labs Inc., Bristol Myers Squibb Co. ,Merck & Co. Inc.,Novartis AG, Sanofi SA, Teva Pharmaceutical Inc., AstraZeneca plc, Catalysis SL, Crinetics Pharmaceuticals Inc., Dexa Medica Group, EffRx Inc., Neurocrine Biosciences Inc.

To view the table of contents for this market research report please visit
http://www.reportstack.com/product/153537/global-pcos-drugs-market-2014-2018.html
Contact:
Roger Campbell
contactus@reportstack.com
Naperville
Illinois
United States
Ph: 888-789-6604
###